Final Guidance Clarifies Distribution Requirements For MedGuides

Final policy on distribution of Medication Guides and inclusion in Risk Evaluation and Mitigation Strategies makes clear what FDA considers a material change.

One exception to FDA’s new policy of reducing requirements to disseminate Medication Guides is if there is a material change to the MedGuide, such as a new indication or new safety information, according to the agency’s final guidance.

“Medication Guides – Distribution Requirements and Inclusion in Risk Evaluation and Mitigation Strategies (REMS)” explains how FDA will use discretion...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Compliance

More from Pink Sheet